The ocular plaque consists of an assembly of discrete sources. (A) Cross section of a 12 mm brachytherapy applicator with 16 sources; (B) the applicator is surrounded by 1.3 mm thick gold shielding to ...

LONDON--(BUSINESS WIRE)--Technavio has announced its newest market research report on the global brachytherapy devices market for the period 2018-2022, providing the latest developments in this market ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the brachytherapy devices market and it is poised to grow by USD 388.62 million during 2020-2024, progressing at a CAGR of about 8% during the ...

In what could prove to be a transformational development in cancer treatment, Vivos (OTCQB: RDGL), the maker of the Radiogel™ Precision Radionuclide Therapy, submitted an application to the U.S. Food ...

The Food and Drug Administration recently granted Salutaris Medical Devices market clearance for its SMD-Sr90-DA Radionuclide Brachytherapy Source device. The SMD-Sr90-DA RBS device is intended for ...

The recently published Brachytherapy Devices Market Report 2023, spanning 105pages, offers a comprehensive overview of the market's current state, size, volume, and market share. In today's rapidly ...

The brachytherapy devices market is poised to grow by USD 327.21 million during 2021-2025, progressing at a CAGR of about 7% during the forecast period. Here is an Exclusive report talking about ...

ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron ® brachytherapy afterloader ...

Please provide your email address to receive an email when new articles are posted on . The first patient has been treated in a clinical trial of an ophthalmic brachytherapy device for neovascular age ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has granted 510(k) clearance for the SMD-Sr90-DA ...

Clinical efficacy of 2-day versus 5-day accelerated partial breast irradiation delivered via balloon-based brachytherapy: Results of a matched pair analysis. This is an ASCO Meeting Abstract from the ...